{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:53:33Z","timestamp":1786737213600,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pathol Microbiol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijpm.ijpm_657_19","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T03:38:12Z","timestamp":1598240292000},"page":"388","source":"Crossref","is-referenced-by-count":1,"title":["A clinicopathological study of triple-negative breast carcinoma in a patient cohort from a tertiary care center in Sri Lanka"],"prefix":"10.4103","volume":"63","author":[{"given":"HarshimaD","family":"Wijesinghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janakie","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upul","family":"Senarath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GayaniK","family":"Wijesinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MenakaD","family":"S. Lokuhetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0377-4929.291683-1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3121\/cmr.2008.825","article-title":"Breast cancer subtypes based on ER\/PR and Her2 expression: Comparison of clinicopathological features and survival","author":"Onitilo","year":"2009","journal-title":"Clin Med Res"},{"key":"key-10.4103\/0377-4929.291683-2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/2193-1801-3-553","article-title":"The treatment and survival of patients with triple negative breast cancer in a London population","author":"Pal","year":"2014","journal-title":"SpringerPlus"},{"key":"key-10.4103\/0377-4929.291683-3","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.22618","article-title":"Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative and HER2 negative invasive breast cancer, the so called triple negative phenotype: A population-based study from the California cancer registry","author":"Bauer","year":"2007","journal-title":"Cancer"},{"key":"key-10.4103\/0377-4929.291683-4","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.7314\/APJCP.2013.14.4.2231","article-title":"HER-2\/new status: A neglected marker of breast cancer patients in India","author":"Zubeda","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"key-10.4103\/0377-4929.291683-5","first-page":"239","article-title":"Triple negative breast cancer: An Indian perspective","author":"Aktar","year":"2015","journal-title":"Breast Cancer"},{"key":"key-10.4103\/0377-4929.291683-6","first-page":"933","article-title":"A study of triple negative breast cancer at a tertiary cancer care center in Southern India","author":"Lakshmaiah","year":"2014","journal-title":"Ann Med Health Sci Res","ISSN":"https:\/\/id.crossref.org\/issn\/2141-9248","issn-type":"print"},{"key":"key-10.4103\/0377-4929.291683-7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1746-1596-9-43","article-title":"Clinicopathological features of triple negative breast cancers: An experience from Pakistan","author":"Hashmi","year":"2014","journal-title":"Diagn Pathol"},{"key":"key-10.4103\/0377-4929.291683-8","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1002\/cncr.27581","article-title":"Clinicopathological features, patterns of recurrence, and survival among women with triple-negative breast cancer in the national comprehensive cancer network","author":"Lin","year":"2012","journal-title":"Cancer"},{"key":"key-10.4103\/0377-4929.291683-9","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s00268-016-3422-4","article-title":"Outcomes of triple-negative breast cancers (TNBC) compared with non-TNBC: Does the survival vary for all stages?","author":"Agarwal","year":"2016","journal-title":"World J Surg"},{"key":"key-10.4103\/0377-4929.291683-10","first-page":"163","article-title":"Triple negative breast cancer: An institutional analysis","author":"Gogia","year":"2014","journal-title":"Indian J Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0019-509X","issn-type":"print"},{"key":"key-10.4103\/0377-4929.291683-11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/modpathol.2009.145","article-title":"Triple-negative breast cancer: Clinicopathological characteristics and relationship with basal-like breast cancer","author":"Thike","year":"2010","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0377-4929.291683-12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/modpathol.2010.200","article-title":"Basal-like and triple-negative breast cancers: A critical review with an emphasis on the implications for pathologists and oncologists","author":"Badve","year":"2011","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0377-4929.291683-13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5858\/arpa.2012-0439-RA","article-title":"Basal-Like Breast Cancer.Update on Clinicopathologic, Immunohistochemical, and Molecular Features","author":"Leidy","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"key-10.4103\/0377-4929.291683-14","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","article-title":"Basal- like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype","author":"Cheang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0377-4929.291683-15","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","article-title":"Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma","author":"Nielsen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0377-4929.291683-16","unstructured":"Ellis IO, Al-Sam S. Anderson N, Carder P, Deb R, Girling A, et al. Pathology reporting of breast disease is surgical excision specimens incorporating the dataset for histological reporting of breast cancer. London: The Royal College of Pathologists; 2016."},{"key":"key-10.4103\/0377-4929.291683-17","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind CH, editors. International Union against Cancer (UICC): TNM Classification of Malignant Tumors. 7th ed. Oxford: Wiley Blackwell; 2009."},{"key":"key-10.4103\/0377-4929.291683-18","unstructured":"Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Viyer MJ, editors. WHO Classification of Tumours of the Breast. Lyon: International Agency for Research on Cancer; 2012."},{"key":"key-10.4103\/0377-4929.291683-19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer: Experience from a large study with long term follow up","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"key-10.4103\/0377-4929.291683-20","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","author":"Harvey","year":"1999","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0377-4929.291683-21","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for Human Epidermal Growth Factor Receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Update","author":"Wolff","year":"2013","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0377-4929.291683-22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1369\/jhc.3A6195.2004","article-title":"Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: Variation in staining intensity due to choice of fixative and storage time of tissue sections","author":"Atkins","year":"2004","journal-title":"J Histochem Cytochem"},{"key":"key-10.4103\/0377-4929.291683-23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1200\/JCO.2012.45.9859","article-title":"Breast cancer follow-up and management after primary treatment: American society of clinical oncology clinical practice guideline update","author":"Khatcheressian","year":"2013","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0377-4929.291683-24","unstructured":"National Cancer Control Programme Ministry of Health Sri Lanka. Early detection and management of breast symptoms. National Cancer Control Programme 2014."},{"key":"key-10.4103\/0377-4929.291683-25","first-page":"610","article-title":"Clinicopathological and prognostic characteristics of triple- negative breast cancer","author":"Tian","year":"2008","journal-title":"Onkologie"},{"key":"key-10.4103\/0377-4929.291683-26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2014.17322","article-title":"Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States","author":"Iqbal","year":"2015","journal-title":"JAMA"},{"key":"key-10.4103\/0377-4929.291683-27","first-page":"133","article-title":"Hormone receptor expression and Her\/2 neu amplification in breast carcinoma in a cohort of Sri Lankans","author":"Ratnatunga","year":"2007","journal-title":"Ceylon Med J"},{"key":"key-10.4103\/0377-4929.291683-28","first-page":"21","article-title":"Pathological characteristics of triple negative breast cancer phenotype in a cohort of Sri Lankan females","author":"Wathuge","year":"2015","journal-title":"J Diagn Pathol"},{"key":"key-10.4103\/0377-4929.291683-29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1200\/JGO.2016.005397","article-title":"Prevalence of triple-negative breast cancer in India: Systematic review and meta-analysis","author":"Sandhu","year":"2016","journal-title":"J Glob Oncol"},{"key":"key-10.4103\/0377-4929.291683-30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.mjafi.2015.04.006","article-title":"Prevalence of molecular subtypes of invasive breast cancer: A retrospective study","author":"Kumar","year":"2015","journal-title":"Med J Armed Forces India"},{"key":"key-10.4103\/0377-4929.291683-31","first-page":"12","article-title":"Expression of basal markers in triple negative breast carcinomas and correlation with proliferation marker in patients attending a tertiary healthcare center","author":"Sharma","year":"2015","journal-title":"Glob J Breast Cancer Res"},{"key":"key-10.4103\/0377-4929.291683-32","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1309\/AJCPQN8GZ8SILKGN","article-title":"Triple negative breast carcinoma.Current and emerging concepts","author":"Schmadeka","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/0377-4929.291683-33","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/modpathol.2012.244","article-title":"Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles","author":"Gazinska","year":"2013","journal-title":"Mod Pathol"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:51:37Z","timestamp":1786733497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJPM.IJPM_657_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"alternative-id":["291683"],"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_657_19","relation":{},"ISSN":["0377-4929"],"issn-type":[{"value":"0377-4929","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}